Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
latanoprost 0.005% eye drops and brimonidine 0.1% eye drops
latanoprost 0.005% eye drops and brinzolamide 1.0% eye drops
Locations
1
United States
Atlanta, Georgia, United States
Start Date
July 1, 2006
Primary Completion Date
March 1, 2007
Completion Date
March 1, 2007
Last Updated
January 2, 2008
NCT04354545
NCT07298356
NCT07396441
NCT06979752
NCT07390890
NCT07145073
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions